Compare WOR & SLNO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | WOR | SLNO |
|---|---|---|
| Founded | 1955 | 1999 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Aerospace | Biotechnology: Electromedical & Electrotherapeutic Apparatus |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.8B | 2.3B |
| IPO Year | 1994 | 2014 |
| Metric | WOR | SLNO |
|---|---|---|
| Price | $47.08 | $34.16 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 3 | 11 |
| Target Price | $59.67 | ★ $108.00 |
| AVG Volume (30 Days) | 108.5K | ★ 1.3M |
| Earning Date | 03-16-2026 | 05-29-2026 |
| Dividend Yield | ★ 1.62% | N/A |
| EPS Growth | N/A | ★ 108.90 |
| EPS | ★ 1.25 | 0.39 |
| Revenue | ★ $1,153,762,000.00 | $1,450,788.00 |
| Revenue This Year | $18.05 | $155.44 |
| Revenue Next Year | $5.29 | $57.99 |
| P/E Ratio | ★ $37.56 | $94.31 |
| Revenue Growth | N/A | ★ 138.82 |
| 52 Week Low | $39.05 | $32.63 |
| 52 Week High | $70.91 | $89.12 |
| Indicator | WOR | SLNO |
|---|---|---|
| Relative Strength Index (RSI) | 21.52 | 32.76 |
| Support Level | N/A | $32.63 |
| Resistance Level | $56.72 | $44.60 |
| Average True Range (ATR) | 1.53 | 2.45 |
| MACD | -0.99 | -0.18 |
| Stochastic Oscillator | 8.75 | 14.19 |
Worthington Enterprises Inc is a designer and manufacturer of products and services, including manufactured metal products. The company operates under two reportable operating segments: Consumer Products and Building Products. The consumer Products business has a diverse product offering in the tools, outdoor living and celebrations categories, including propane-filled cylinders for torches, handheld torches, specialized hand tools, drywall tools, accessories and gas grills, and others. And the Building Products business engaged in providing pressurized containment solutions, providing critical components in the residential, non-residential, and repair and remodel end markets through essential categories. The company derives majority of the revenue from Building Products segment.
Soleno Therapeutics Inc is a biopharmaceutical company developing novel therapeutics for the treatment of rare diseases. Its product candidate DCCR (Diazoxide Choline) Extended-Release tablets, is a proprietary extended-release formulation of a crystalline salt of diazoxide. DCCR has demonstrated the ability to activate the KATP channel in the brain, pancreas, and fat tissue.